Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Sleep in Children With Autism
NCT05546554Phase 2Recruiting
- Sponsor
- Stanford University
- Start
- Aug 2023
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suvorexant in Autism Spectrum Disorder (ASD), insomnia disorder, sponsored by Stanford University. Started Aug 2023; status: recruiting.
02
Drugs
suvorexant
03
Conditions
Autism Spectrum Disorder (ASD)insomnia disorder
Beyond the preview
Go deeper on NCT05546554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05546554.